TY - JOUR
T1 - Pancreatic metastasis from differentiated thyroid cancer
T2 - A case report
AU - Matsuo, Mioko
AU - Uchi, Ryutaro
AU - taura, masahiko
AU - Wakasaki, Takahiro
AU - Yasumatsu, Ryuji
AU - Nakagawa, Takashi
N1 - Publisher Copyright:
© 2020, Japan Society for Head and Neck Cancer. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Distant metastasis occurs occasionally in differentiated thyroid cancer patients, with the lungs and bones being the most frequent locations. An extremely rare location of distant metastasis is the pancreas, as reported in only 16 published cases. In this article we report a case with pancreatic metastases from thyroid papillary carcinoma. A 71-year-old woman underwent total thyroidectomy for thyroid papillary carcinoma with lung metastases. While the patient was undergoing TSH suppression therapy, the thyroid cancer spread to the pancreas. She began receiving Lenvatinib, a molecular-targeted drug, which was very effective, and the lung and pancreatic metastases diminished during 15 months. In rare cases like pancreatic metastasis from differentiated thyroid cancer, the standard of care is unclear. If the case has a condition that cannot be removed with surgery, or cannot be treated by RAI therapy, we believe that molecular-targeted drugs might be a good treatment as one of the choices.
AB - Distant metastasis occurs occasionally in differentiated thyroid cancer patients, with the lungs and bones being the most frequent locations. An extremely rare location of distant metastasis is the pancreas, as reported in only 16 published cases. In this article we report a case with pancreatic metastases from thyroid papillary carcinoma. A 71-year-old woman underwent total thyroidectomy for thyroid papillary carcinoma with lung metastases. While the patient was undergoing TSH suppression therapy, the thyroid cancer spread to the pancreas. She began receiving Lenvatinib, a molecular-targeted drug, which was very effective, and the lung and pancreatic metastases diminished during 15 months. In rare cases like pancreatic metastasis from differentiated thyroid cancer, the standard of care is unclear. If the case has a condition that cannot be removed with surgery, or cannot be treated by RAI therapy, we believe that molecular-targeted drugs might be a good treatment as one of the choices.
UR - http://www.scopus.com/inward/record.url?scp=85099840544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099840544&partnerID=8YFLogxK
U2 - 10.5981/jjhnc.46.385
DO - 10.5981/jjhnc.46.385
M3 - Article
AN - SCOPUS:85099840544
SN - 1349-5747
VL - 46
SP - 385
EP - 389
JO - Japanese Journal of Head and Neck Cancer
JF - Japanese Journal of Head and Neck Cancer
IS - 4
ER -